Your browser doesn't support javascript.
loading
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.
Gane, Edward J; Kowdley, Kris V; Pound, David; Stedman, Catherine A M; Davis, Mitchell; Etzkorn, Kyle; Gordon, Stuart C; Bernstein, David; Everson, Gregory; Rodriguez-Torres, Maribel; Tsai, Naoky; Khalid, Omer; Yang, Jenny C; Lu, Sophia; Dvory-Sobol, Hadas; Stamm, Luisa M; Brainard, Diana M; McHutchison, John G; Tong, Myron; Chung, Raymond T; Beavers, Kimberly; Poulos, John E; Kwo, Paul Y; Nguyen, Mindie H.
Affiliation
  • Gane EJ; Auckland Clinical Studies, Auckland, New Zealand. Electronic address: edgane@adhb.govt.nz.
  • Kowdley KV; Swedish Medical Center, Seattle, Washington.
  • Pound D; Indianapolis Gastroenterology Research Foundation, Indianapolis, Indiana.
  • Stedman CA; Christchurch Hospital and University of Otago, Christchurch, New Zealand.
  • Davis M; Digestive CARE-South Florida Center of Gastroenterology, Wellington, Florida.
  • Etzkorn K; Borland-Groover Clinic, Jacksonville, Mississippi.
  • Gordon SC; Henry Ford Hospital and Health System, Detroit, Michigan.
  • Bernstein D; North Shore/Long Island Jewish PRIME, Manhasset, New York.
  • Everson G; University of Colorado, Aurora, Colorado.
  • Rodriguez-Torres M; Fundación De Investigación De Diego, San Juan, Puerto Rico.
  • Tsai N; Queens Liver Center, Honolulu, Hawaii.
  • Khalid O; Digestive Health Specialists, Winston-Salem, North Carolina.
  • Yang JC; Gilead Sciences, Foster City, California.
  • Lu S; Gilead Sciences, Foster City, California.
  • Dvory-Sobol H; Gilead Sciences, Foster City, California.
  • Stamm LM; Gilead Sciences, Foster City, California.
  • Brainard DM; Gilead Sciences, Foster City, California.
  • McHutchison JG; Gilead Sciences, Foster City, California.
  • Tong M; Huntington Medical Research Institutes Liver Center, Pasadena, California.
  • Chung RT; Massachusetts General Hospital, Boston, Massachusetts.
  • Beavers K; Medical University of South Carolina, Charleston, South Carolina.
  • Poulos JE; Cumberland Research Associates, LLC, Fayetteville, Georgia.
  • Kwo PY; Indiana University School of Medicine, Indiana.
  • Nguyen MH; Stanford University Medical Center, Palo Alto, California.
Gastroenterology ; 151(5): 902-909, 2016 11.
Article in En | MEDLINE | ID: mdl-27486033
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Sulfonamides / Carbamates / Hepacivirus / Hepatitis C, Chronic / Macrocyclic Compounds / Sofosbuvir / Heterocyclic Compounds, 4 or More Rings Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Gastroenterology Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Sulfonamides / Carbamates / Hepacivirus / Hepatitis C, Chronic / Macrocyclic Compounds / Sofosbuvir / Heterocyclic Compounds, 4 or More Rings Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Gastroenterology Year: 2016 Type: Article